# Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

> **NCT01302834** · PHASE3 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 987 (actual)

## Conditions studied

- Head and Neck Cancer
- Precancerous Condition

## Interventions

- **BIOLOGICAL:** cetuximab
- **DRUG:** cisplatin
- **RADIATION:** IMRT

## Key facts

- **NCT ID:** NCT01302834
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2018-07-12
- **Final completion:** 2025-09-04
- **Target enrollment:** 987 (ACTUAL)
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01302834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01302834, "Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01302834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*